Daniel O'Connor
Chief Executive Officer presso AMBRX INC
Patrimonio netto: 316 $ in data 31/03/2024
Profilo
Daniel J.
O'Connor founded Ambrx Biopharma Cayman, Inc. in 2022, where he is working as President, Chief Executive Officer & Director from 2022 and Larkspur Health Acquisition Corp.
in 2021, where he worked as Chairman & Chief Executive Officer.
Mr. O'Connor also founded Larkspur Health LLC, where he is working as Manager.
Mr. O'Connor also currently works at Ambrx, Inc., as President, Chief Executive Officer & Director and Seelos Therapeutics, Inc., as Director from 2019.
Mr. O'Connor also formerly worked at inVentiv Health Clinical, Inc., as Chief Executive Officer, OncoSec Medical, Inc., as President, Chief Executive Officer & Director from 2018 to 2021, Advaxis, Inc., as President, Chief Executive Officer & Director from 2013 to 2017, Ambrx Biopharma, Inc., as President, Chief Executive Officer & Director from 2023 to 2024, Apricus Biosciences, Inc., as Director, ZyVersa Therapeutics Operating, Inc., as Director, ZyVersa Therapeutics, Inc., as Independent Director from 2022 to 2023, ImClone LLC, as Secretary, Senior Vice President & General Counsel from 2002 to 2008, Celanese Corp., as Principal, PharmaNet, Inc., as General Counsel from 1998 to 2001, United States Marine Corps, as Captain, Bracco Diagnostics, Inc., as Senior Vice President & General Counsel from 2008 to 2012, BioNJ, Inc., as Trustee from 2015 to 2021, and Syneos Health, Inc., as General Counsel from 1998 to 2001.
Mr. O'Connor received his undergraduate degree from Boston University, graduate degree in 1995 from Dickinson Law School, and undergraduate degree in 1998 from Usmc Officer Candidates School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 04/01/2024 | 534 ( 0.00% ) | 316 $ | 31/03/2024 | |
| 12/12/2022 | 0 ( nan% ) | - $ | 31/03/2024 |
Posizioni attive di Daniel O'Connor
| Società | Posizione | Inizio |
|---|---|---|
| SEELOS THERAPEUTICS, INC. | Director/Board Member | 01/01/2019 |
| AMBRX INC | Chief Executive Officer | - |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Founder | 01/11/2022 |
| Larkspur Health LLC | Founder | - |
Precedenti posizioni note di Daniel O'Connor
| Società | Posizione | Fine |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Director/Board Member | 18/05/2023 |
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 24/06/2021 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Director/Board Member | 01/01/2021 |
| AYALA PHARMACEUTICALS, INC. | Chief Executive Officer | 06/07/2017 |
Formazione di Daniel O'Connor
| Boston University | Undergraduate Degree |
| Dickinson Law School | Graduate Degree |
| Usmc Officer Candidates School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CELANESE CORPORATION | Process Industries |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| SEELOS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 15 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Distribution Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
| United States Marine Corps | Government |
Bracco Diagnostics, Inc.
 Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Larkspur Health Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on March 17, 2021 and is headquartered in Bridgewater, NJ. | Finance |
| Larkspur Health LLC | |
| ZyVersa Therapeutics, Inc. |
- Borsa valori
- Insiders
- Daniel O'Connor
